von Borstel & Associates’s AbbVie ABBV Stock Holding History

von Borstel & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,741	Closed	-$1.25M	–	41
2025 Q3	$1.25M	Buy	+5,741	New	+$1.17M	0.19%	60

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

von Borstel & Associates's ABBV Position: Q4 2025 in Review

von Borstel & Associates sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 5,741 shares — an estimated $1.25M sold.

von Borstel & Associates first reported a position in ABBV in Q3 2025 and held it in 1 quarter. The position peaked at $1.25M in Q3 2025. 4,158 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

von Borstel & Associates reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
von Borstel & Associates sold 5,741 AbbVie shares in Q4 2025, an estimated $1.25M.
von Borstel & Associates first reported a position in AbbVie in Q3 2025 and held it in 1 quarter.
von Borstel & Associates's AbbVie position peaked at $1.25M in Q3 2025.
4,158 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on von Borstel & Associates's 13F filing for Q4 2025, filed 12 Feb 2026.